koryu

editas medicine crispr/cas9 investment

Long
koryu Aktualisiert   
NASDAQ:EDIT   Editas Medicine, Inc.
12
I enter long as long term investment in CRISPR/Cas9 technology.

There is still a patent battle going on, thats why there is the big dump in the chart.

Buying here feels like catching the knife, so buying slowly over time.


Trade ist aktiv:
nice start. also watching NTLA
Kommentar:
was lucky and got in at 13.40$

There was a bullish divergence on daily rsi. Now watching carefully if it is an additional inv h+s forming. Really like this stock. Ready to increase position if bottom is confirmed.

Kommentar:
increasing position in this dip
Kommentar:
pitchfork scenario
Kommentar:
adjusted pitchfork and channel, fits really good! would be amazing bull market (must break out the channel!) definitly watch this
Kommentar:
break out channel and horizontal resistance! <3
Kommentar:
EW
Kommentar:
bounced on the potential pitchfork and formed a weekly hammer candle which tested the long term downtrend in bullish manner
Kommentar:
HODL the double up :D

Haftungsausschluss

Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.